Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High or Low. Nasal Nitric Oxide Across Mutations in Primary Ciliary Dyskinesia. A Genotype/Phenotype Analysis of Nasal NO in Patients With PCD Within the European Reference Network (ERN)

NCT04949308 is registered in ClinicalTrials.gov with University Hospital Muenster as lead sponsor.

NCT NCT04949308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04949308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High or Low. Nasal Nitric Oxide Across Mutations in Primary Ciliary Dyskinesia. A Genotype/Phenotype Analysis of Nasal NO in Patients With PCD Within the European Reference Network (ERN)
Lead sponsor
University Hospital Muenster
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2021
Completion date
December 31, 2022
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ciliary motility disorders, primary ciliary dyskinesia